BioStock: BiBBInstruments ready for active near-term future

In its report for the first half of the year, BiBBInstruments highlights a completed pilot study in muscle-invasive bladder cancer, a successful presentation at the DDW congress, and a high level of regulatory activity. Another eventful period awaits, bringing the company closer to its goal of revolutionising cancer diagnostics with EndoDrill.

Read the article at biostock.se:

https://www.biostock.se/en/2022/08/bibbinstruments-star-infor-en-handelserik-fas/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/